Cambridge Investment Research Advisors
IBDX icon

Cambridge Investment Research Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$883K Buy
35,048
+17,203
+96% +$433K ﹤0.01% 2429
2026
Q1 		$451K Buy
17,845
+3,741
+27% +$95.4K ﹤0.01% 2893
2025
Q4 		$360K Buy
+14,104
New +$361K ﹤0.01% 3020

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $458M AUM 17.27% 1-Year Est. Return
SVWAG
Sound View Wealth Advisors Group Savannah, Georgia $1.61B AUM 26.11% 1-Year Est. Return

Cambridge Investment Research Advisors's IBDX Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 96% in Q2 2026, buying an estimated $433K and bringing the position to 35,048 shares worth $883K. The position accounts for ﹤0.01% of the portfolio, ranked #2429.

Cambridge Investment Research Advisors first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 199 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Cambridge Investment Research Advisors held 35,048 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $883K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 17,203 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $433K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2429 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 199 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.